BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough colorectal cancer before surgery
Disease control CompletedThis study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. Only 2 participants were enrolled. The goal was to see how well the drugs shrink the t…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
New study tracks how melanoma patients use a smartphone app during targeted treatment
Knowledge-focused CompletedThis study observed about 400 adults with advanced BRAF-mutant melanoma who were taking targeted therapy (BRAF/MEK inhibitors) and using a smartphone app called TavieSkin. The goal was to describe patient characteristics, how they used the app, and their quality of life. No new t…
Matched conditions: BRAF V600 MUTATION
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC